REVA Medical, Inc. 4
4 · REVA Medical, Inc. · Filed Jun 30, 2016
Insider Transaction Report
Form 4
REVA Medical, Inc.RVA:AX
Brandom Donald K.
VP, Biomaterials Product Dev
Transactions
- Sale
Common Stock
2016-06-28$7.33/sh−994.6$7,286→ 70,050 total
Footnotes (2)
- [F1]Represents the sale of 9,946 of the Company's Chess Depository Interests (CDIs) trading on the Australian Securities Exchange ("ASX").
- [F2]The sale was executed in the form of CDIs trading on the ASX and, as such, the sale price has been converted to a USD equivalent, adjusting for the conversion ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction.